Activist 13D/13G Filings - Spero Therapeutics Inc. (SPRO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-14
5:37 pm
Sale
13GSpero Therapeutics Inc.
SPRO
Anson Funds Management LP3,750,450
6.900%
-547,149decrease
(-12.73%)
View
2024-02-14
4:25 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
Anson Funds Management LP4,297,599
8.100%
4,297,599increase
(New Position)
View
2023-02-14
11:47 am
Sale
13GSpero Therapeutics Inc.
SPRO
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-3,411,520decrease
(Position Closed)
View
2023-02-14
11:16 am
Sale
13GSpero Therapeutics Inc.
SPRO
Aquilo Capital Management LLC0
0.000%
-3,419,435decrease
(Position Closed)
View
2023-01-20
4:08 pm
Unchanged
13DSpero Therapeutics Inc.
SPRO
GSK plc
GSK
9,190,606
17.750%
0
(Unchanged)
View
2022-11-14
5:02 pm
Purchase
13DSpero Therapeutics Inc.
SPRO
GSK plc
GSK
9,190,606
19.990%
7,450,000increase
(+428.01%)
View
2022-10-03
4:40 pm
Sale
13GSpero Therapeutics Inc.
SPRO
Aquilo Capital Management LLC3,419,435
9.800%
-1,602,101decrease
(-31.90%)
View
2022-07-08
4:57 pm
Sale
13GSpero Therapeutics Inc.
SPRO
BlackRock Inc.
BLK
690,753
2.100%
-1,108,024decrease
(-61.60%)
View
2022-03-08
5:41 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
Aquilo Capital Management LLC5,021,536
15.500%
57,355increase
(+1.16%)
View
2022-02-14
3:54 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
Aquilo Capital Management LLC4,964,181
15.400%
1,031,972increase
(+26.24%)
View
2022-02-14
1:27 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
BIOTECHNOLOGY VALUE FUND L P3,411,520
9.990%
643,242increase
(+23.24%)
View
2022-02-03
4:29 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
BlackRock Inc.
BLK
1,798,777
5.600%
67,177increase
(+3.88%)
View
2022-01-25
11:28 am
Unchanged
13GSpero Therapeutics Inc.
SPRO
Atlas Venture Fund IX L.P.1,376,968
4.260%
0
(Unchanged)
View
2021-09-16
5:27 pm
Unchanged
13DSpero Therapeutics Inc.
SPRO
GSK plc
GSK
1,740,606
5.400%
0
(Unchanged)
View
2021-07-09
4:25 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
PFIZER INC
PFE
2,362,348
7.370%
2,362,348increase
(New Position)
View
2021-02-16
5:29 pm
Unchanged
13DSpero Therapeutics Inc.
SPRO
Atlas Venture Fund X L.P.1,031,160
3.800%
0
(Unchanged)
View
2021-02-16
4:00 pm
Sale
13GSpero Therapeutics Inc.
SPRO
Aquilo Capital Management LLC3,932,209
14.500%
-564,933decrease
(-12.56%)
View
2021-02-12
8:16 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
BIOTECHNOLOGY VALUE FUND L P2,768,278
9.990%
739,873increase
(+36.48%)
View
2021-02-10
4:37 pm
Sale
13GSpero Therapeutics Inc.
SPRO
GV 2015 L.P.889,979
3.270%
-222,494decrease
(-20.00%)
View
2021-02-02
3:13 pm
Purchase
13GSpero Therapeutics Inc.
SPRO
BlackRock Inc.
BLK
1,731,600
6.400%
1,731,600increase
(New Position)
View
Goto 0, 1, Next